ライフサイエンスコーパス: DRB

1 DRB carbohydrates were resistant to simulated gastrointe

2 DRB induced the appearance of short 0.4 to 0.8 kb TCRbet

3 DRB reduced the TNF-alpha-induced increase in MMP-9 mRNA

4 DRB sensitivity-inducing factor (DSIF or Spt4/5) is a co

5 DRB sequences isolated from three exotic cats demonstrat

6 DRB-induced apoptosis was independent of the cell cycle

7 7 of the 14 DRB molecules (DRB1*0401, 0101, 0404, 0405, DRB5*0101, D

8 tro binding of the OspA163-175 peptide to 14 DRB molecules.

9 ced the peptide binding regions (PBRs) of 41 DRB (= E beta) genes and eight DRA (= E alpha) genes fro

10 dentified, together with 19 DRB1*0406 and 43 DRB*w201 selective binders.

11 tored inhibition of microtubule sliding in a DRB- and CK1-7-sensitive manner.

12 We have isolated a DRB- and heparin-sensitive protein kinase activity that

13 tion at higher levels of DRB suggests that a DRB-resistant/stress-activated pathway may target serine

14 After DRB removal, cells are collected at several time points,

15 ition, p53 accumulating in the nucleus after DRB treatment was able to interact with MDM2 and was ubi

16 tested this hypothesis and found that after DRB treatment, p53 accumulated despite the fact that MDM

17 n sequencing (NGS) was used to determine all DRB alleles in consecutively diagnosed patients ages 1-1

18 The new alleles DRB*23 and DRB*24, were closely related to two other Ovc

19 with recombinant retroviruses for allogeneic DRB followed by BM transplantation.

20 Also, DRB abolished the inhibitory effect of the NMDAR antagon

21 promoter polymorphism might lead to altered DRB gene expression, which could possibly affect the TLR

22 ARC than to the well-known nucleoside analog DRB (5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole),

23 ces imply extensive maintenance of ancestral DRB alleles across species.

24 The new alleles DRB*23 and DRB*24, were closely related to two other Ovca-DRB exon

25 t with HMBA (hexamethylene bisacetamide) and DRB (5,6-dichlorobenzimidazole 1-beta-ribofuranoside), w

26 nd restores sensitivity to actinomycin D and DRB.

27 f apoptosis by M protein, actinomycin D, and DRB was inhibited in stably transfected HeLa cell lines

28 Transcripts of the MHC class II DRA and DRB gene homologues of the domestic cat (Felis catus) we

29 man and mouse MHCs, the domestic cat DRA and DRB genes have undergone multiple duplications and the D

30 absolute and relative rate tests on DRA and DRB genes imply increased substitution rates at two- and

31 , X2BP, NF-Y, and X-Y box DNA of the DRA and DRB genes were formed.

32 To test this hypothesis, DRA and DRB transcripts from 24 captive BHS (Ovca-DRA and Ovca-D

33 merly, casein kinase II), such as emodin and DRB, were able to duplicate the effects of H7 and H89.

34 ence of the cdk9 inhibitors Flavopiridol and DRB (5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole) a

35 we compared the ability of flavopiridol and DRB to inhibit transcription in vivo using nuclear run-o

36 e heat-shock response, little RNA Pol II and DRB sensitivity-inducing factor (DSIF) are reused for it

37 Negative elongation factor (NELF) and DRB sensitivity inducing factor (DSIF) contribute in the

38 is activity depends on both its RNaseIII and DRB domains.

39 protocols for carrying out TT(chem)-seq and DRB/TT(chem)-seq, including computational analysis.

40 The Mamu-DRB1*0406 and -DRB*w201 binding capacity of a set of 311 overlapping pe

41 ors rescued IFN-gamma-inducible HLA-DRA and -DRB mRNA and cell surface protein expression, demonstrat

42 l domain (CTD) of RNA polymerase II, such as DRB and H7, induced rapid nuclear accumulation of p53 pr

43 erences were observed in the number of A, B, DRB, DQA, and DQB VerEp.

44 , especially disinfection residual bacteria (DRB) carrying multidrug-resistant plasmids (MRPs).

45 loro-1-beta- D -ribofuranosyl benzimidazole (DRB), a potent inhibitor of CDK9, the protein kinase sub

46 chloro-1-beta-D-ribofuranosyl benzimidazole (DRB), did not affect the enhancement of exocytosis produ

47 chloro-1-beta-d-ribofuranosyl-benzimidazole (DRB) and heparin.

48 chloro-1-beta-D-ribofuranosyl-benzimidazole (DRB) as well as by the kinase inhibitor H8 at concentrat

49 6-dichloro-1-D-ribofuranosyl-benzimidazole (DRB) or actinomycin D.

50 chloro-1-beta-d-ribofuranosyl-benzimidazole (DRB) suppressed CTD phosphorylation (especially serine 2

51 carries one RNaseIII and two dsRNA binding (DRB) domains, is a unique Arabidopsis RNaseIII enzyme re

52 is encodes five double-stranded RNA binding (DRB) proteins.

53 oLA-DRB3 allele-binding regions using a BoLA-DRB- peptide binding affinity prediction algorithm.

54 f p70 S6 kinase, which was inhibited by both DRB and flavopiridol.

55 n aerogels produced from defatted rice bran (DRB), an underutilized rice processing byproduct, using

56 tract carbohydrates from defatted rice bran (DRB), and the prebiotic activity of the extracted carboh

57 topo I activity were unaltered by the brief DRB treatment.

58 ts Cdk9, we found that inhibition of Cdk9 by DRB or by siRNA could recapitulate the flavopiridol effe

59 PAIR-Emu interactions are not disrupted by DRB, which blocks transcription elongation without disru

60 inhibition of CK2 phosphorylation events by DRB (5,6-dichlorobenzimidazole) resulted in dramatic sen

61 found that long transcripts were induced by DRB from both the tet-responsive and beta-actin promoter

62 Transcriptional inhibition by DRB or by triptolide reveals that promoter G4 formation,

63 r release from transcriptional inhibition by DRB treatment, was suppressed in MEN epsilon/beta-deplet

64 l for in vitro transcriptional repression by DRB and activation by the Tat protein.

65 uced accumulation of MMP-2 was unaffected by DRB.

66 nd recipient are matched for HLA-A, -B, -C, -DRB, -DQB1 and -DPB1 alleles.

67 longation rates in vivo, a technique we call DRB/TT(chem)-seq.

68 e association with a particular domestic cat DRB lineage, suggesting that these allelic lineages are

69 g of a single spirochetal peptide to certain DRB molecules is a marker for antibiotic-refractory Lyme

70 identified a second new and highly conserved DRB family (we named DRB7) whose members possess a singl

71 Consistently DRB and dominant-negative CDK9 completely abrogated TNF-

72 the RNA synthesis inhibitors actinomycin D, DRB, H7 and alpha-amanitin.

73 Treatment of cells with actinomycin D, DRB, or alpha-amanitin, specific inhibitors of Pol II, d

74 o blocked by dichlorofuranosylbenzimidazole (DRB), an inhibitor of transcription.

75 eca-DRB gene was seen comprising 61 distinct DRB alleles.

76 ividual cats contained three to six distinct DRB sequences, indicating that feline MHC maintains two

77 We obtain three distinctive DRB-carried MRPs (pWWTP-01-03) from postdisinfection eff

78 lineages), mouse (H-2Ebeta b, u, f), and dog DRB alleles.

79 urs after treatment, depending on the dose), DRB dramatically increased the levels of IVS1(Cbeta1)-co

80 olymerase II (Pol II) elongation by the drug DRB, suggesting also a negative role in vivo.

81 -NELF (negative elongation factor) and DSIF (DRB sensitivity-inducing factor)--and P-TEFb (positive e

82 Pol IIo(ser5)), and the pausing factor DSIF (DRB sensitivity-inducing factor) are still present at th

83 recruitment of the elongation factors DSIF (DRB Sensitivity-Inducing Factor), P-TEFb (Positive Trans

84 ants, four distinct clades of multiple dsRBM DRBs are always present with the exception of Brassicace

85 enetic approach, we show that multiple dsRBM DRBs are systematically composed of two different types

86 ptional elongation in the presence of either DRB or the HIV-1 Tat protein.

87 mical inhibitor of transcription elongation, DRB, had no effect on ASH1 recruitment or H3K27 methylat

88 mplicating segmental exchange of MHC-encoded DRB gene fragments as one of the evolutionary mechanisms

89 tive location and directionality of the Eqca-DRB, -DQA, -DQB and -DOB loci.

90 zoans that requires the transcription factor DRB sensitivity-inducing factor (DSIF) and the inhibitor

91 ociation of transcription elongation factors DRB-sensitivity inducing factor (DSIF) and Negative Elon

92 observed, but abundant variation in the Feca-DRB gene was seen comprising 61 distinct DRB alleles.

93 s resolved at least five monophyletic feline DRB allelic lineages (DRB*1 to *5), which are clearly di

94 urrence of recent gene duplication of feline DRB genes.

95 selection for nonrecognition sites of feline DRB sequences--in the process of evolution of DR molecul

96 ot prevent the accumulation of p53 following DRB treatment.

97 ons suggest that the developed aerogels from DRB have the potential to serve as vehicles for deliveri

98 Furthermore, some MRPs from DRB are capable of transferring and could confer selecti

99 Furthermore, DRB significantly decreased the firing activity of PVN n

100 ranscriptional activity, resulting in higher DRB expression and subsequently perturbed Ag presentatio

101 501) and Class II alleles (HLA-DRB*0401, HLA-DRB*0401 and HLA-DRB*0701).

102 02 and HLA-B*3501) and Class II alleles (HLA-DRB*0401, HLA-DRB*0401 and HLA-DRB*0701).

103 llele level for HLA-A, HLA-B, HLA-C, and HLA-DRB (n=116), or mismatched (n=166).

104 alleles (HLA-DRB*0401, HLA-DRB*0401 and HLA-DRB*0701).

105 These data suggest that certain HLA-DRB and DQB1 alleles, also associated with other T-cell-

106 When the other expressed HLA-DRB loci were examined, homozygosity for HLA-DRB4*01, en

107 n of collagen-induced arthritis (CIA) in HLA-DRB*0101+/+ (HLA-DR1+/+) mice, we investigated the immun

108 replicating a PheWAS on rs3135388 (near HLA-DRB, associated with multiple sclerosis) and performing

109 point analysis identified low levels of HLA-DRB (< 20%) and high levels of MYC (> 80%) as independen

110 GAD65 274-286 epitope in the context of HLA-DRB 1*0401, was incubated with antigen-presenting cells

111 genome editing to simultaneously target HLA-DRB, -DQB1, and -DPB1 through a single guide RNA recogni

112 The data suggest that HLA-DRB*11 may offer protection from trichiasis in trachoma

113 allele-specific amplification within the HLA-DRB locus.

114 nt studies have shifted the focus to the HLA-DRB locus.

115 nalyze sequence variation at these three HLA-DRB loci.

116 lovirus glycoprotein B presented through HLA-DRB*0701.

117 st class II beta chains, more similar to HLA-DRB, clawed frog Xela-F3, and nurse shark Gici-B.

118 ation analyses were performed on the two HLA-DRB loci haplotypes (DRB1-DRB3, -DRB4, or -DRB5).

119 Homologous DRB exon 2 sequences from 36 feral domestic cats through

120 number variation (CNV) at the hypervariable DRB locus within the MHC region to HPV seropositivity at

121 MHC class I-disparate, and one MHC class II DRB allele-matched rhesus macaques.

122 or histocompatibility complex (Mhc) class II DRB alleles, spanning 237 codons, were analyzed for phyl

123 allogeneic (n=4) or syngeneic (n=1) class II DRB genes and a drug-resistance marker.

124 ing animals, we found six different class II DRB major histocompatibility sequences.

125 cells with CTD kinase inhibitors, including DRB (5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole),

126 ates that GTAT haplotype exerts an increased DRB transcriptional activity, resulting in higher DRB ex

127 8 kb TCRbeta transcripts in vivo, indicating DRB enhances premature transcriptional termination.

128 that the kinase and mRNA synthesis inhibitor DRB (5,6-dichloro-1-b-D-ribofuranosylbenzimidazole) indu

129 ption elongation factor-b (P-TEFb) inhibitor DRB (5,6-dichloro 1-beta-d-ribofuranosylbenzinida-sole).

130 sensitivity to the transcriptional inhibitor DRB and to stimulate transcription at limiting nucleotid

131 phorylation or the transcriptional inhibitor DRB, prevented the reduced arteriolar tone and the enhan

132 0-fold excess of the commonly used inhibitor DRB, suggesting that the immobilized P-TEFb could be use

133 ion of P-TEFb function by the Cdk-inhibitor, DRB, or by small interfering RNA selectively blocked TNF

134 The CK1 inhibitors (DRB and CK1-7) and solubilization of CK1 restored microt

135 Instead, DRB reduces accumulation of gamma2 late mRNA in the cyto

136 Interestingly, DRB and siRNA reduced the levels of ICP22 but not those

137 ve monophyletic feline DRB allelic lineages (DRB*1 to *5), which are clearly distinct from those of h

138 t depleted of P-TEFb failed to generate long DRB-sensitive transcripts, but this activity was restore

139 ted extract lost the ability to produce long DRB-sensitive transcripts and this loss was reversed by

140 e describe five macaque MHC-II alleles (Mamu-DRB*w606, -DRB*w2104, -DRB1*0306, -DRB1*1003, and -DPB1*

141 esus macaque alleles Mamu-DRB1*0406 and Mamu-DRB*w201 have been purified, and quantitative binding as

142 ope in C5 was found to be restricted by Mamu-DRB*W201.

143 u-DRB1*0406 restricted) and HIV Env482 (Mamu-DRB*w201 restricted).

144 five offspring were identical at their Mamu-DRB loci, MHC class II differences are unlikely to accou

145 icted HA 307-319 epitope for binding to Mamu-DRB*w201 and HLA-DRB1*0101.

146 hosen for testing included both nuclear (MHC DRB) and mitochondrial DNA (cytochrome b) genes.

147 enic exchange generates repeated sets of MHC DRB polymorphisms.

148 We analyzed over 50 primate MHC DRB sequences, and identified nucleotide elements within

149 gnificant linkage disequilibrium between MHC-DRB and MHC-DOB, suggesting that these loci are unlikely

150 d alleles in white-tailed deer to 30 for MHC-DRB exon 2.

151 mily, with the exception of the Class II MHC-DRB genes.

152 We identified 12 new MHC-DRB alleles, and resampled 7 alleles, which along with o

153 Overall, this study identified 12 new MHC-DRB exon 2 alleles and characterized a new, non-classica

154 We sequenced MHC-DRB exon 2 (IIa) and MHC-DOB exon 2 (IIb) on the MiSeq p

155 ntiation and recycling of alleles at the MHC-DRB loci, suggesting that TB imposes strong PMBS on wild

156 While MHC-DRB was found to be under positive, diversifying selecti

157 her single nucleotide polymorphisms in MHCII-DRB regulatory gene may be associated with clinical outc

158 Moreover, DRB potently inhibited HIV-1 expression in chronically i

159 Patterns of ancestral polymorphism in mouse DRB alleles were also used to examine the tempo of synon

160 rations of topotecan or camptothecin but not DRB.

161 eta1)), consistent with the known ability of DRB to inhibit transcription.

162 Finally, addition of DRB reduces co-immunoprecipitation of ICP27 using an ant

163 However, the characteristics of DRB-carried MRPs are poorly understood.

164 The effect of DRB could not be explained by inhibition of DNA replicat

165 addition, we establish two novel effects of DRB not previously reported: intron stabilization and th

166 increased CK2alpha level and the effects of DRB on mEPSCs and NMDA-EPSCs.

167 We identified three other effects of DRB.

168 To examine the evolution of DRB alleles in related species, a phylogenetic analysis

169 dition, intracerebroventricular injection of DRB not only significantly reduced blood pressure and lu

170 Selective injection of DRB or emetine into the presynaptic or postsynaptic neur

171 transactivation function at higher levels of DRB suggests that a DRB-resistant/stress-activated pathw

172 Within 30 min of DRB removal, topo I relocalized to the nucleoli in the a

173 t kinase 9 (CDK9) for the phosphorylation of DRB sensitivity-inducing factor, negative elongation fac

174 lony-forming progenitors and the presence of DRB retrovirus transcripts in peripheral cells.

175 fficiency but is reversed by the presence of DRB sensitivity-inducing factor (DSIF).

176 ase-8 and cleavage of Bid in the presence of DRB, thereby facilitating the release of proapoptotic fa

177 e to efficiently elongate in the presence of DRB.

178 ll, this study advances our understanding of DRB-carried MRPs and highlights the imminent need to mon

179 xamined the role of four DCLs, two AGOs, one DRB, and one RDR in controlling viral RNA accumulation i

180 Only DRB, the CK2 inhibitor, greatly reduced the amount of (3

181 Treatment with JQ1 (inhibitor of BRD4) or DRB (inhibitor of CDK9) decreases SHM and the abundance

182 ymes, as did treatment with actinomycin D or DRB.

183 of apoptosis by M protein, actinomycin D, or DRB.

184 Posttraining infusion of either U0126 or DRB significantly impaired long-term retention of fear c

185 y is DRB4-independent, and may involve other DRB proteins that compensate for loss of DRB4.

186 Nineteen out of 24 BHS (79%) Ovca-DRB exon 3 (beta2 domain) sequences were 100% identical

187 ripts from 24 captive BHS (Ovca-DRA and Ovca-DRB) were sequenced.

188 ca leukotoxin peptides to T(h) cells by Ovca-DRB alleles is equivalent to that of Ovar-DRB1 alleles.

189 eta1 domain) sequences, eight different Ovca-DRB cDNA sequences were identified in BHS.

190 ned genetic polymorphism at a MHC gene (Ovca-DRB) in a large sample, both numerically and geographica

191 sequences, this BHS herd yielded higher Ovca-DRB allelic diversity than that reported in the previous

192 B*24, were closely related to two other Ovca-DRB exon 2 genomic DNA sequences.

193 e 100% identical to previously reported Ovca-DRB genomic DNA sequences.

194 In the first phase, DRB caused a rapid decrease (within five minutes) of pre

195 9/cyclin T2b produced in Sf9 cells possessed DRB-sensitive kinase activity and functioned in transcri

196 e five double-stranded RNA binding proteins (DRBs) related to Drosophila R2D2 and mammalian TRBP and

197 plant double-stranded RNA binding proteins (DRBs), a group of non-catalytic factors containing one o

198 ute proteins (AGOs), dsRNA-binding proteins (DRBs), and RNA-dependent RNA polymerases (RDRs).

199 Remarkably, DRB inhibition sensitized cells to TNF-alpha-induced apo

200 le explanation for why RB expression rescues DRB inducibility in H2009.

201 and 5,6-dichloro-1-beta-D-ribobenzimidazole (DRB) and an siRNA targeting p300 on the presence of RNAP

202 th 5, 6-dichloro-1-beta-D-ribobenzimidazole (DRB), an RNA Pol II-dependent transcription elongation i

203 hlorobenzimidazole 1-beta-d-ribofurandoside (DRB), a reversible RNA synthesis inhibitor, also prevent

204 chlorobenzimidazole 1-beta-D-ribofuranoside (DRB) to estimate the elongation rates of over 2000 indiv

205 chlorobenzimidazole 1-beta-D-ribofuranoside (DRB), to measure RNA polymerase II (RNAPII) elongation r

206 chlorobenzimidazone-1-beta-d-ribofuranoside (DRB).

207 ichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) and 1-(5-isoquinolinesulfonyl)-2-methylpiperazine (

208 ichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) and alpha-amanitin, which inhibit RNAP II function

209 ichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) and alpha-amanitin.

210 ichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) and H-8.

211 ichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) at concentrations that inhibited [3H]uridine incorp

212 ichloro-1-beta-d-ribofuranosylbenzimidazole (DRB) blocked the splicing alteration induced by CPT, whi

213 ichloro-1-beta-d-ribofuranosylbenzimidazole (DRB) is an adenosine analog that has been shown to cause

214 ichloro-1-beta-d-ribofuranosylbenzimidazole (DRB) or 4,5,6,7-tetrabromobenzotriazole (TBB) significan

215 ichloro-1-beta-d-ribofuranosylbenzimidazole (DRB) sensitivity inducing factors (DSIF) and the negativ

216 ichloro-1-beta-d-ribofuranosylbenzimidazole (DRB) sensitivity-inducing factor (DSIF).

217 ichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) sensitivity-inducing factor and found that the IC(5

218 ichloro-1-beta-D-ribofuranosylbenzimidazole (DRB), a compound that causes premature termination.

219 ichloro-1-beta-d-ribofuranosylbenzimidazole (DRB), a CTD kinase inhibitor.

220 ichloro-1-beta-D-ribofuranosylbenzimidazole (DRB), a dominant-negative CDK9, and a CDK9-specific smal

221 ichloro-1-beta-d-ribofuranosylbenzimidazole (DRB), a specific inhibitor of cdk9.

222 ichloro-1-beta-D-ribofuranosylbenzimidazole (DRB), an inhibitor of CDK7 TFIIH-associated kinase, CKI

223 ichloro-1-beta-d-ribofuranosylbenzimidazole (DRB), an inhibitor of CDK9, suppresses expression of gam

224 ichloro-1-beta-D-ribofuranosylbenzimidazole (DRB), and actinomycin.

225 ichloro-1-beta-D-ribofuranosylbenzimidazole (DRB), can partially inhibit the UV-induced phosphorylati

226 ichloro-1-beta-D-ribofuranosylbenzimidazole (DRB), combined with a pulse of 4-thiouridine (4sU), to t

227 ichloro-1-beta-D-ribofuranosylbenzimidazole (DRB), or infusion of the protein synthesis inhibitor ani

228 ichloro-1-beta-D-ribofuranosylbenzimidazole (DRB), which inhibits the Tat-associated kinase, TAK (CDK

229 ichloro-1-beta-D-ribofuranosylbenzimidazole (DRB)-mediated transcriptional inhibition and the activat

230 ichloro-1-beta-D-ribofuranosylbenzimidazole (DRB).

231 ichloro-1-beta-D-ribofuranosylbenzimidazole (DRB, a CK2 inhibitor).

232 ichloro-1-beta-D-ribofuranosylbenzimidazole [DRB]-sensitivity-inducing factor) and the negative elong

233 cin D or 5,6-dichlorobenzimidazole riboside (DRB) causes VHL to be redistributed to the nucleus.

234 cin D or 5,6-dichlorobenzimidazole riboside (DRB).

235 Second, DRB upregulated full-length normal-sized c-myc mRNA, whi

236 cell cycle or ongoing DNA replication, since DRB induced similar levels of apoptosis in asynchronous

237 e establish an efficient system for studying DRB-sensitive steps of transcriptional elongation.

238 w that meerkats carrying the MHC allele Susu-DRB*13 were initially more likely to develop clinical si

239 cted the resilience effect conferred by Susu-DRB*13.

240 Meerkats carrying Susu-DRB*13 also showed slower progression to TB signs and lo

241 owed by an increase in the frequency of Susu-DRB*13.

242 A control animal, which received a syngeneic DRB gene, rejected its kidney allograft in 120 days afte

243 These results demonstrate that DRB carbohydrates can be considered a potential source o

244 c mRNA, which provided further evidence that DRB has effects besides regulation of premature terminat

245 The fact that DRB kills tumour-derived cells without employment of DNA

246 We found that DRB had a biphasic effect on T-cell receptor-beta (TCRbe

247 Hence, we hypothesized that DRB gene promoter polymorphism might lead to altered DRB

248 of the intron IVS1(Cbeta1), indicating that DRB exerts post-transcriptional actions.

249 First, we observed that DRB induced the appearance of heterodisperse TCRbeta tra

250 models of codon substitution to analyze the DRB genes of six mammalian species: human, chimpanzee, m

251 ive to primates, and decreased rates for the DRB genes of primates relative to ungulate and carnivore

252 analysis detected positive selection in the DRB genes in each of the six mammals examined.

253 strong evidence for genetic variation in the DRB locus of the MHC (HLA) II region that predisposes in

254 elongs to a monocot-specific subgroup of the DRB family and contains a noncanonical MAPK interaction

255 ferences based upon the exon 2 region of the DRB loci are complicated by selection and recombination,

256 study was to determine which, if any, of the DRB proteins might also participate in a nuclear siRNA p

257 elongation factor SPT5, large subunit of the DRB sensitivity-inducing factor (DSIF), undergoes spatio

258 However, the inability of the DRB*0101 molecule to bind hLFA-1alpha(L330-342) suggests

259 with kidney allografts solely matched to the DRB transgene.

260 330-342) showed only an association with the DRB*04 alleles.

261 Third, DRB stabilized lariat forms of the intron IVS1(Cbeta1),

262 Five cats had three DRB sequences in a single allelic lineage, indicating th

263 ating that feline MHC maintains two to three DRB loci.

264 units in common, P-TEFb is more sensitive to DRB than is TFIIH, and most importantly, TFIIH cannot su

265 dramatically increased their sensitivity to DRB, directly demonstrating that apoptosis following inh

266 nitin without affecting their sensitivity to DRB, indicating that alpha-amanitin induces apoptosis so

267 tract desensitizes transcription in vitro to DRB.

268 afts, but with DRB matched to the transduced DRB, the one with the highest gene transduction rate sho

269 Two DRB chains, DRB5*0101 and DRB1*1501, are co-expressed in

270 15 shared two DRB DQB haplotypes.

271 nitiation complex (PIC) remained unaffected, DRB, an inhibitor of P-TEFb, prevented RNAPII from elong

272 compounds and add value to the underutilized DRB.

273 A plot of LHRH mRNA level per cell versus DRB treatment time showed a rapid initial decay of LHRH

274 five macaque MHC-II alleles (Mamu-DRB*w606, -DRB*w2104, -DRB1*0306, -DRB1*1003, and -DPB1*06) that re

275 While DRB proteins have defined roles in miRNA and cytoplasmic

276 fully mismatched kidney allografts, but with DRB matched to the transduced DRB, the one with the high

277 The results obtained with DRB were duplicated in cells transfected with small inte

278 ho-p70 S6 kinase, and neurons protected with DRB and flavopiridol showed accumulation of the kinase i

279 In cells treated with DRB, the major effect was in the accumulation of viral R

280 Treatment with DRB had little effect on the presence of RNAPII or p300

281 inhibition can be rescued by treatment with DRB or H7.

282 Treatment with DRB or TBB significantly reduced the amplitude of evoked